Atossa Therapeutics
(NASDAQ) ATOS
Atossa Therapeutics Financials at a Glance
Market Cap
$53.13M
Revenue (TTM)
$0.00
Net Income (TTM)
$34.77M
EPS (TTM)
$-4.04
P/E Ratio
-1.53
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$6.18
Volume
1,230
Open
$5.80
Price
$6.18
Volume
1,230
Open
$5.80
Previous Close
$6.18
Daily Range
$5.80 - $6.20
52-Week Range
$3.76 - $19.35
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$6.18
Volume
1,230
Open
$5.80
Previous Close
$6.18
Daily Range
$5.80 - $6.20
52-Week Range
$3.76 - $19.35
ATOS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Atossa Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Steven C. Quay, MD, PhD
Website
www.atossatherapeutics.comHeadquarters
Seattle, WA 98104, US
ATOS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-63%
Return on Capital
-94%
Return on Assets
-73%
Earnings Yield
-65.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$53.13M
Shares Outstanding
8.61M
Volume
1.23K
Short Interest
0.00%
Avg. Volume
122.47K
Financials (TTM)
Gross Profit
$16.00K
Operating Income
$37.14M
EBITDA
$37.13M
Operating Cash Flow
$29.76M
Capital Expenditure
$23.00K
Free Cash Flow
$29.79M
Cash & ST Invst.
$41.30M
Total Debt
$0.00
Atossa Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.00K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$53.13M
N/A
Market Cap/Employee
$3.54M
N/A
Employees
15
N/A
Net Income
$10.94M
-72.3%
EBITDA
$11.43M
-60.0%
Quarterly Fundamentals
Net Cash
$41.30M
-41.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-73.03%
N/A
Return on Invested Capital
-94.38%
N/A
Free Cash Flow
$10.55M
-49.6%
Operating Cash Flow
$10.54M
-49.5%